Literature DB >> 18586319

Good prognosis, clinical features, and circumstances of peanut and tree nut reactions in children treated by a specialist allergy center.

Andrew T Clark1, Pamela W Ewan.   

Abstract

BACKGROUND: The diagnosis of nut allergy causes anxiety. Few studies exist that estimate risk of reactions and inform management.
OBJECTIVE: To describe frequency and circumstances of reactions after the institution of a management plan.
METHODS: Prospective study of children with peanut/nut allergy with an allergist's management plan. Severity and circumstances of worst reaction before diagnosis (index) and follow-up reactions were evaluated.
RESULTS: A total of 785 children were followed for 3640 patient-years from diagnosis. Index reactions were mild in 66% (516), moderate in 29% (224), and severe in 5% (45). Fourteen percent (114/785) had follow-up reactions (3% annual incidence rate). Ninety percent had the same/reduced severity grade, and 1 of 785 (0.1%) had a severe reaction. Preschool children (n = 263) had a low incidence of reactions, and none were severe. There was a 3-fold reduction in injected epinephrine use from that used in the index reaction, required in 1 severe reaction, never twice; 14% (16/114) required no medication, 78% only oral antihistamines. Forty-eight percent reacted to the index nut type, 19% to a different nut (55% sensitized at diagnosis, 14% not sensitized, 31% not tested). Accidental versus index reactions were 4-fold more likely to be a result of contact exposure rather than ingestion. Contact reactions were always mild. Most (53%) reactions occurred at home, 5% in school, 21% at other sites (21% not recorded). The nut was given by a parent/self in 69 (61%) reactions or teacher in 5 (4%).
CONCLUSION: With a comprehensive management plan, accidental reactions were uncommon and usually mild, most requiring little treatment; 99.8% self-treated appropriately and 100% effectively.

Entities:  

Mesh:

Year:  2008        PMID: 18586319     DOI: 10.1016/j.jaci.2008.05.015

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  19 in total

1.  Using 'may contain' labelling to inform food choice: a qualitative study of nut allergic consumers.

Authors:  Julie Barnett; Kate Muncer; Jo Leftwich; Richard Shepherd; Monique M Raats; M Hazel Gowland; Kate Grimshaw; Jane S Lucas
Journal:  BMC Public Health       Date:  2011-09-26       Impact factor: 3.295

2.  Peanut oral immunotherapy is not ready for clinical use.

Authors:  Ananth Thyagarajan; Pooja Varshney; Stacie M Jones; Scott Sicherer; Robert Wood; Brian P Vickery; Hugh Sampson; A Wesley Burks
Journal:  J Allergy Clin Immunol       Date:  2010-07       Impact factor: 10.793

3.  Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children.

Authors:  A Thyagarajan; S M Jones; A Calatroni; L Pons; M Kulis; C S Woo; M Kamalakannan; B P Vickery; A M Scurlock; A Wesley Burks; W G Shreffler
Journal:  Clin Exp Allergy       Date:  2012-08       Impact factor: 5.018

Review 4.  Allergic reaction to peanuts: can we predict reaction severity in the wild?

Authors:  Aisling Flinn; Jonathan O'B Hourihane
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

Review 5.  Clinical Immunology Review Series: An approach to the patient with allergy in childhood.

Authors:  R Sporik; J Henderson; J O'B Hourihane
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

Review 6.  Epidemiology of severe anaphylaxis: can we use population-based data to understand anaphylaxis?

Authors:  Paul J Turner; Dianne E Campbell
Journal:  Curr Opin Allergy Clin Immunol       Date:  2016-10

7.  The strategies that peanut and nut-allergic consumers employ to remain safe when travelling abroad.

Authors:  Julie Barnett; Neil Botting; M Hazel Gowland; Jane S Lucas
Journal:  Clin Transl Allergy       Date:  2012-07-09       Impact factor: 5.871

Review 8.  Clinical immunology.

Authors:  J David M Edgar
Journal:  Ulster Med J       Date:  2011-01

9.  Management of anaphylaxis in schools: Evaluation of an epinephrine auto-injector (EpiPen®) use by school personnel and comparison of two approaches of soliciting participation.

Authors:  Nha Uyen Nguyen Luu; Lisa Cicutto; Lianne Soller; Lawrence Joseph; Susan Waserman; Yvan St-Pierre; Ann Clarke
Journal:  Allergy Asthma Clin Immunol       Date:  2012-07-09       Impact factor: 3.406

Review 10.  Uses of phage display in agriculture: a review of food-related protein-protein interactions discovered by biopanning over diverse baits.

Authors:  Rekha Kushwaha; Christina M Payne; A Bruce Downie
Journal:  Comput Math Methods Med       Date:  2013-04-28       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.